trial · primary record
Montanide (Registered Trademark) ISA-51 VG Adjuvant
Non-Small Cell Lung Cancer
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2035-12-30 |
| Primary endpoint | Phase II Component: To assess the frequency of immunologic responses to purified CT-X and autosomal CT antigens in NSCLC participants following vaccinations with H1299 cancer cell lysate and Montanide ISA-51 VG adjuvant in combination with N-803 |
| Registry ID | NCT05642195 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:51.806Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05642195
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.